Excellent AI tool for daily accurate use…enjoy it.

Hypokalemia ⚡ + Frequent PVCs 🫀 Post-CAR T. 🔍 Causes.•💩 GI loss: diarrhea (infection, GVHD, drug-related).•🩸 Renal loss: diuretics, CNIs, amphotericin.•🔄 Intracellular shift: catecholamine surge (CRS), insulin.•🍽 Poor intake. ⸻. ⚠️ Why dangerous?.•Low K⁺ → ↑.

Sorafenib — Comprehensive Review (Adults). ⸻. 🔹 Class & Mechanism.•Class: Oral multikinase inhibitor (TKI).•Targets:.•Tumor cell proliferation: RAF kinases (CRAF, BRAF, mutant BRAF).•Angiogenesis: VEGFR-1, VEGFR-2, VEGFR-3, PDGFR-β, FLT3, RET, KIT.•Effect: Inhibits tumor.

Frequent PVCs 🫀 — Causes & Management. ⸻. 🔍 Causes.•❤️ Structural: IHD, prior MI, valve dz, LVH, HCM.•⚡ Electrolytes: ↓K⁺, ↓Mg²⁺, ↓Ca²⁺.•🫁 Sleep apnea, myocarditis, sarcoid.•🔥 Stimulants: caffeine, nicotine, EtOH, cocaine.•💊 Drugs: digoxin tox, theophylline.•🌀.

شرح العقيدة الواسطية 11 – من قوله تعالى (وأحسنوا إن الله يحب المحسنين . ) عبر @YouTube.

RT @englishclubber: Stop using VERY

RT @grajhi:

🩸 Perioperative Thrombotic Risk – Quick Guide for Hema Fellows ⚠️. 🔴 High Risk (>10%/mo VTE or >10%/yr ATE). Recent (<3 mo) VTE 🫀.Strong thrombophilia (Protein C/S def., ATIII def., homozygous FVL/PGM, multiple thrombophilias) 🧬.APS 🩸.High-risk cancer: pancreas, brain,

🧠 ICANS after Blinatumomab in B-ALL ⚡💉. 🔍 Definition:.Immune effector cell–associated neurotoxicity syndrome (ICANS) = neurotoxic events from T-cell engager therapy (like blina) causing diffuse brain dysfunction. 📅 Onset: Usually within first week of infusion; can be.

🛡️ Primary vs Secondary Immune Deficiency – How to Differentiate & Work Up 🧬🦠. 🔍 Definitions.•Primary (PID) = inborn errors of immunity, mostly genetic, often start in childhood but some present in adults. •Secondary (SID) = acquired later in life due to external causes like.

🛡️ Secondary Hypogammaglobulinemia after Lymphoma Treatment 💉🩸. 🔍 Definition: ↓ serum IgG/IgA/IgM due to B-cell depletion or marrow suppression after lymphoma therapy. 📅 Causes:.•Anti-CD20 therapy (rituximab, obinutuzumab).•CAR T-cell therapy.•BTK inhibitors.

🩸 Liver Transplant–Associated Immune Thrombocytopenia (LT-ITP) 🫀🫁. 🔍 Definition: De novo or recurrent immune-mediated platelet destruction after liver transplant. 📅 Onset: Weeks–months post-OLT; sometimes early in pediatric recipients. ⚠️ Triggers:.•Immune dysregulation.

🐰 B-PLL – 75% TP53+, BTKi±CD20.MCQ: TP53 mut = very aggressive ✅.OSCE: Ibrutinib±rituximab; HSCT. 🐺 T-PLL – Same as above, very aggressive.MCQ: TP53 mut common ✅.OSCE: Alemtuzumab→HSCT. 🏗 Post-IS lymphoma – Aggressive.MCQ: TP53 mut = poor OS ���.OSCE: R-CHOP±novel; trial.

🧬 TP53 mutation – Hematology 50 diseases exam sheet. 🐼 MDS – ↓OS ≤9mo, chemo-resistant.MCQ: TP53 in MDS → poor OS ✅.OSCE: Elderly, TP53+, choose HMA±VEN, discuss HSCT early. 🩸 AML – ELN adverse, poor CR.MCQ: TP53 mut in AML = adverse risk ✅.OSCE: Fit → CR1 HSCT; unfit.

RT @r7a1ll: أذآنٌ بنبرةٍ قديمة:

RT @r7a1ll: #تلاوات_دون_تكلف

RT @UsuarezMD: PRCA approach. By @CarmeloGurnari

RT @fodiifhd:

RT @hadith_alnubui:

RT @OGdukeneurosurg: Airway tools